{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:04:36Z","timestamp":1791839076109,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303518"],"award-info":[{"award-number":["82303518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503810"],"award-info":[{"award-number":["82503810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403712"],"award-info":[{"award-number":["82403712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404027"],"award-info":[{"award-number":["82404027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270830"],"award-info":[{"award-number":["82270830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573420"],"award-info":[{"award-number":["82573420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB072"],"award-info":[{"award-number":["2022CFB072"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH156"],"award-info":[{"award-number":["ZR2022MH156"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mechanism underlying thyroid cancer progression and treatment resistance remains an unsolved problem in clinical practice. Endoplasmic reticulum (ER) proteins modulate cell biosynthesis and mediate tumor progression, among which Reticulon 3 (RTN3) is verified to play important roles in cancers. However, its effect in thyroid cancer has not been clarified. Meanwhile, cholesterol is found to contribute to proliferation and drug resistance in many tumors. As ER is the primary site of cholesterol synthesis, we aimed to study how RTN3 regulates cholesterol concentration and influences tumor progression and sensitivity to MEK inhibitors in thyroid cancer. This study found that RTN3 is low-expressed in thyroid cancer, and is related to poor prognosis and insensitivity to MEK inhibitors. It binds to a cholesterol synthesis enzyme DHCR7 and promotes its ubiquitination. Downregulation of RTN3 lead to stabilization of DHCR7 and elevate cholesterol concentration, activating EGFR\/ERK pathway and contributes to progression of thyroid cancer, which can be rescued by HMG-CoA reductase inhibitor Simvastatin. We identified RTN3 as a tumor suppressor and a biomarker of sensitivity to MEK inhibitors and verified the role of cholesterol in drug resistance. The combination of statins provides a novel therapeutic method in patients resistant to MEK inhibitors.<\/jats:p>","DOI":"10.1038\/s41419-026-08538-y","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:17:34Z","timestamp":1773242254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Declined RTN3 stabilizes DHCR7 to induce cholesterol-dependent tumor progression and MEK inhibitors insensitivity in thyroid cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3559","authenticated-orcid":false,"given":"Anwen","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2504-4591","authenticated-orcid":false,"given":"Tinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-8621","authenticated-orcid":false,"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-0701","authenticated-orcid":false,"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"8538_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians. 2024;74:229\u201363.","journal-title":"CA A Cancer J Clinicians"},{"key":"8538_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, et al. Controversies, consensus, and collaboration in the Use of131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29:461\u201370.","journal-title":"Thyroid"},{"key":"8538_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. JAMA. 2024;331:425.","journal-title":"JAMA"},{"key":"8538_CR4","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn B-C. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics. 2021;11:6251\u201377.","journal-title":"Theranostics"},{"key":"8538_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21:71\u201388.","journal-title":"Nat Rev Cancer"},{"key":"8538_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21:421\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8538_CR7","doi-asserted-by":"publisher","first-page":"111378","DOI":"10.1016\/j.biopha.2021.111378","volume":"137","author":"C Zhou","year":"2021","unstructured":"Zhou C, Li J, Du J, Jiang X, Xu X, Liu Y, et al. HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis. Biomedicine & Pharmacotherapy. 2021;137:111378.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"8538_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijms20040857","volume":"20","author":"L Sisinni","year":"2019","unstructured":"Sisinni L, Pietrafesa M, Lepore S, Maddalena F, Condelli V, Esposito F, et al. Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance. IJMS. 2019;20:857.","journal-title":"IJMS"},{"key":"8538_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1136\/gutjnl-2020-321386","volume":"70","author":"S Song","year":"2021","unstructured":"Song S, Shi Y, Wu W, Wu H, Chang L, Peng P, et al. Reticulon 3-mediated Chk2\/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut. 2021;70:2159\u201371.","journal-title":"Gut"},{"key":"8538_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metabolism. 2020;31:62\u201376.","journal-title":"Cell Metabolism"},{"key":"8538_CR11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","volume":"76","author":"OF Kuzu","year":"2016","unstructured":"Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Research. 2016;76:2063\u201370.","journal-title":"Cancer Research"},{"key":"8538_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2015.12.010","volume":"23","author":"W Wei","year":"2016","unstructured":"Wei W, Schwaid AG, Wang X, Wang X, Chen S, Chu Q, et al. Ligand activation of err\u03b1 by cholesterol mediates statin and bisphosphonate effects. Cell Metabolism. 2016;23:479\u201391.","journal-title":"Cell Metabolism"},{"key":"8538_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1534-5807(03)00031-5","volume":"4","author":"A Gallet","year":"2003","unstructured":"Gallet A, Rodriguez R, Ruel L, Therond PP. Cholesterol modification of Hedgehog is required for trafficking and movement, revealing an asymmetric cellular response to Hedgehog. Developmental Cell. 2003;4:191\u2013204.","journal-title":"Developmental Cell"},{"key":"8538_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07082-x","volume":"15","author":"C-Y Sun","year":"2024","unstructured":"Sun C-Y, Cao D, Wang Y-N, Weng N-Q, Ren Q-N, Wang S-C, et al. Cholesterol inhibition enhances antitumor response of gilteritinib in lung cancer cells. Cell Death Dis. 2024;15:704.","journal-title":"Cell Death Dis"},{"key":"8538_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4757-z","volume":"18","author":"S Hultsch","year":"2018","unstructured":"Hultsch S, Kankainen M, Paavolainen L, Kovanen R-M, Ikonen E, Kangaspeska S, et al. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer. 2018;18:850.","journal-title":"BMC Cancer"},{"key":"8538_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-022-02261-0","volume":"41","author":"S Yu","year":"2022","unstructured":"Yu S, Wang L, Che D, Zhang M, Li M, Naito M, et al. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. J Exp Clin Cancer Res. 2022;41:88.","journal-title":"J Exp Clin Cancer Res"},{"key":"8538_CR17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-23-2889","volume":"84","author":"S Wan","year":"2024","unstructured":"Wan S, He Q-Y, Yang Y, Liu F, Zhang X, Guo X, et al. SPARC Stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma. Cancer Research. 2024;84:1872\u201388.","journal-title":"Cancer Research"},{"key":"8538_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100670","volume":"49","author":"J Kopecka","year":"2020","unstructured":"Kopecka J, Trouillas P, Ga\u0161parovi\u0107 A\u010c, Gazzano E, Assaraf YG, Riganti C. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets. Drug Resistance Updates. 2020;49:100670.","journal-title":"Drug Resistance Updates"},{"key":"8538_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116974","volume":"238","author":"J Li","year":"2025","unstructured":"Li J, Guo Y, Zhang W, Xia M, Liu G, Sun Y, et al. Cholesterol metabolism: a strategy for overcoming drug resistance in tumors. Biochemical Pharmacology. 2025;238:116974.","journal-title":"Biochemical Pharmacology"},{"key":"8538_CR20","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1021\/acs.jproteome.1c00550","volume":"20","author":"X-D Wang","year":"2021","unstructured":"Wang X-D, Kim C, Zhang Y, Rindhe S, Cobb MH, Yu Y. Cholesterol regulates the tumor adaptive resistance to MAPK pathway inhibition. J Proteome Res. 2021;20:5379\u201391.","journal-title":"J Proteome Res"},{"key":"8538_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12672-024-01684-9","volume":"15","author":"H Liang","year":"2024","unstructured":"Liang H, Tang C, Sun Y, Wang M, Tong T, Gao Q, et al. Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers. Discov Onc. 2024;15:798.","journal-title":"Discov Onc"},{"key":"8538_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14373-9","volume":"25","author":"Z Ning","year":"2025","unstructured":"Ning Z, Yi H, Yang T, Liu J, Su S, He T, et al. Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer. BMC Cancer. 2025;25:1203.","journal-title":"BMC Cancer"},{"key":"8538_CR23","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s12672-025-03483-2","volume":"16","author":"X-X Li","year":"2025","unstructured":"Li X-X, Shi P, Wu F-F, Li D. Identification of novel cholesterol metabolism-related biomarkers for thyroid cancer to predict the prognosis, immune infiltration, and drug sensitivity. Discov Onc. 2025;16:1608.","journal-title":"Discov Onc"},{"key":"8538_CR24","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ijc.33333","volume":"148","author":"A Majidi","year":"2021","unstructured":"Majidi A, Na R, Jordan SJ, De Fazio A, Webb PM. OPAL Study Group. Statin use and survival following a diagnosis of ovarian cancer: a prospective observational study. Intl Journal of Cancer. 2021;148:1608\u201315.","journal-title":"Intl Journal of Cancer"},{"key":"8538_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ehjcvp\/pvad057","volume":"9","author":"V Jaiswal","year":"2023","unstructured":"Jaiswal V, Agrawal V, Ang SP, Saleeb M, Ishak A, Hameed M, et al. Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 2023;9:731\u201340.","journal-title":"European Heart Journal - Cardiovascular Pharmacotherapy"},{"key":"8538_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrurol.2016.199","volume":"14","author":"MA Alfaqih","year":"2017","unstructured":"Alfaqih MA, Allott EH, Hamilton RJ, Freeman MR, Freedland SJ. The current evidence on statin use and prostate cancer prevention: are we there yet? Nat Rev Urol. 2017;14:107\u201319.","journal-title":"Nat Rev Urol"},{"key":"8538_CR27","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.ejca.2014.08.005","volume":"50","author":"ST Kim","year":"2014","unstructured":"Kim ST, Kang JH, Lee J, Park SH, Park JO, Park YS, et al. Simvastatin plus capecitabine\u2013cisplatin versus placebo plus capecitabine\u2013cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study. European Journal of Cancer. 2014;50:2822\u201330.","journal-title":"European Journal of Cancer"},{"key":"8538_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-10-2525","volume":"17","author":"J-Y Han","year":"2011","unstructured":"Han J-Y, Lee S-H, Yoo NJ, Hyung LS, Moon YJ, Yun T, et al. A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non\u2013small cell lung cancer. Clinical Cancer Research. 2011;17:1553\u201360.","journal-title":"Clinical Cancer Research"},{"key":"8538_CR29","doi-asserted-by":"crossref","unstructured":"Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis. Clinical Cancer Research. 2020.","DOI":"10.1186\/s13046-020-1528-x"},{"key":"8538_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216496","volume":"580","author":"Z Pan","year":"2024","unstructured":"Pan Z, Lu X, Xu T, Chen J, Bao L, Li Y, et al. Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer. Cancer Letters. 2024;580:216496.","journal-title":"Cancer Letters"},{"key":"8538_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, et al. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression. Mol Cancer. 2022;21:77.","journal-title":"Mol Cancer"},{"key":"8538_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11010-009-0163-9","volume":"331","author":"R Xiang","year":"2009","unstructured":"Xiang R, Zhao S. RTN3 inducing apoptosis is modulated by an adhesion protein CRELD1. Mol Cell Biochem. 2009;331:225\u201330.","journal-title":"Mol Cell Biochem"},{"key":"8538_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10495-006-0574-y","volume":"12","author":"Q Wan","year":"2007","unstructured":"Wan Q, Kuang E, Dong W, Zhou S, Xu H, Qi Y, et al. Reticulon 3 mediates Bcl-2 accumulation in mitochondria in response to endoplasmic reticulum stress. Apoptosis. 2007;12:319\u201328.","journal-title":"Apoptosis"},{"key":"8538_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2009.01.035","volume":"279","author":"JT Lee","year":"2009","unstructured":"Lee JT, Lee T-J, Kim C-H, Kim N-S, Kwon TK. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Cancer Letters. 2009;279:185\u201392.","journal-title":"Cancer Letters"},{"key":"8538_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aah6152","volume":"356","author":"G Caldieri","year":"2017","unstructured":"Caldieri G, Barbieri E, Nappo G, Raimondi A, Bonora M, Conte A, et al. Reticulon 3\u2013dependent ER-PM contact sites control EGFR nonclathrin endocytosis. Science. 2017;356:617\u201324.","journal-title":"Science"},{"key":"8538_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4143\/crt.2023.1278","volume":"56","author":"Y Jeon","year":"2024","unstructured":"Jeon Y, Park S, Lee S-H, Kim TH, Kim SW, Ahn M-J, et al. Combination of dabrafenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer. Cancer Res. Treat. 2024;56:1270\u20136.","journal-title":"Cancer Res. Treat"},{"key":"8538_CR37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1089\/thy.2023.0228","volume":"33","author":"D Balakirouchenane","year":"2023","unstructured":"Balakirouchenane D, Seban R, Groussin L, Puszkiel A, Cottereau AS, Clerc J, et al. Pharmacokinetics\/pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive iodine-resistant mutated advanced differentiated thyroid cancer. Thyroid. 2023;33:1327\u201338.","journal-title":"Thyroid"},{"key":"8538_CR38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/thy.2023.0553","volume":"34","author":"M Tahara","year":"2024","unstructured":"Tahara M, Kiyota N, Imai H, Takahashi S, Nishiyama A, Tamura S, et al. A phase 2 study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan. Thyroid. 2024;34:467\u201376.","journal-title":"Thyroid"},{"key":"8538_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","volume":"36","author":"V Subbiah","year":"2018","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600\u2013mutant anaplastic thyroid cancer. JCO. 2018;36:7\u201313.","journal-title":"JCO"},{"key":"8538_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1176731","volume":"14","author":"S Hamidi","year":"2023","unstructured":"Hamidi S, Hofmann M-C, Iyer PC, Cabanillas ME, Hu MI, Busaidy NL, et al. Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front Endocrinol. 2023;14:1176731.","journal-title":"Front Endocrinol"},{"key":"8538_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song B, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341.","journal-title":"Nat Metab"},{"key":"8538_CR42","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metabolism. 2019;29:1376\u2013.e4.","journal-title":"Cell Metabolism"},{"key":"8538_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature. 2016;531:651\u20135.","journal-title":"Nature"},{"key":"8538_CR44","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.1107710","volume":"307","author":"P Wang","year":"2005","unstructured":"Wang P, Weng J, Anderson RGW. OSBP is a cholesterol-regulated scaffolding protein in control of ERK1\/2 activation. Science. 2005;307:1472\u20136.","journal-title":"Science"},{"key":"8538_CR45","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1158\/0008-5472.CAN-18-3295","volume":"79","author":"S Jiang","year":"2019","unstructured":"Jiang S, Wang X, Song D, Liu X, Gu Y, Xu Z, et al. Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP. Cancer Research. 2019;79:3063\u201375.","journal-title":"Cancer Research"},{"key":"8538_CR46","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1002\/jcp.26351","volume":"233","author":"Q Chen","year":"2018","unstructured":"Chen Q, Pan Z, Zhao M, Wang Q, Qiao C, Miao L, et al. High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer. Journal Cellular Physiology. 2018;233:6722\u201332.","journal-title":"Journal Cellular Physiology"},{"key":"8538_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401\u201310.","journal-title":"Nature"},{"key":"8538_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46386-6","volume":"15","author":"N Yamada","year":"2024","unstructured":"Yamada N, Karasawa T, Ito J, Yamamuro D, Morimoto K, Nakamura T, et al. Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis. Nat Commun. 2024;15:2195.","journal-title":"Nat Commun"},{"key":"8538_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nm.4067","volume":"22","author":"KR Francis","year":"2016","unstructured":"Francis KR, Ton AN, Xin Y, O\u2019Halloran PE, Wassif CA, Malik N, et al. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt\/\u03b2-catenin defects in neuronal cholesterol synthesis phenotypes. Nat Med. 2016;22:388\u201396.","journal-title":"Nat Med"},{"key":"8538_CR50","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205683","author":"Y Wang","year":"2024","unstructured":"Wang Y, Fan J, Liu Y, Du J, Liang B, Wang H, et al. Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer. Aging. 2024. https:\/\/doi.org\/10.18632\/aging.205683.","journal-title":"Aging"},{"key":"8538_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110553","volume":"102","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Y, Huang M, Wang Z, Liu D, Liu J, et al. DHCR7 promotes tumorigenesis via activating PI3K\/AKT\/mTOR signalling pathway in bladder cancer. Cellular Signalling. 2023;102:110553.","journal-title":"Cellular Signalling"},{"key":"8538_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-023-02611-6","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yan W, Yang K, Qian Y, Chen Y, Wang R, et al. Integrated multi-dimensional analysis highlights DHCR7 mutations involving in cholesterol biosynthesis and contributing therapy of gastric cancer. J Exp Clin Cancer Res. 2023;42:36.","journal-title":"J Exp Clin Cancer Res"},{"key":"8538_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/genes10080572","volume":"10","author":"IS Carvalho","year":"2019","unstructured":"Carvalho IS, Gon\u00e7alves CI, Almeida JT, Azevedo T, Martins T, Rodrigues FJ, et al. Association of vitamin D pathway genetic variation and thyroid cancer. Genes. 2019;10:572.","journal-title":"Genes"},{"key":"8538_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ebiom.2017.04.017","volume":"19","author":"Z Yang","year":"2017","unstructured":"Yang Z, Su Z, DeWitt JP, Xie L, Chen Y, Li X, et al. Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy. EBioMedicine. 2017;19:49\u201359.","journal-title":"EBioMedicine"},{"key":"8538_CR55","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41564-023-01363-5","volume":"8","author":"J-X Han","year":"2023","unstructured":"Han J-X, Tao Z-H, Wang J-L, Zhang L, Yu C-Y, Kang Z-R, et al. Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer. Nature Microbiology. 2023;8:919\u201333.","journal-title":"Nature Microbiology"},{"key":"8538_CR56","doi-asserted-by":"publisher","first-page":"e005940","DOI":"10.1136\/jitc-2022-005940","volume":"11","author":"V Kansal","year":"2023","unstructured":"Kansal V, Burnham AJ, Kinney BLC, Saba NF, Paulos C, Lesinski GB, et al. Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models. J Immunother Cancer. 2023;11:e005940.","journal-title":"J Immunother Cancer"},{"key":"8538_CR57","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1535-7163.MCT-23-0458","volume":"23","author":"W Ma","year":"2024","unstructured":"Ma W, Wei S, Li Q, Zeng J, Xiao W, Zhou C, et al. Simvastatin overcomes resistance to tyrosine kinase inhibitors in patient-derived, oncogene-driven lung adenocarcinoma models. Molecular Cancer Therapeutics. 2024;23:700\u201310.","journal-title":"Molecular Cancer Therapeutics"},{"key":"8538_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis. J Exp Clin Cancer Res. 2020;39:24.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08538-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:02:31Z","timestamp":1774987351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8538"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08538-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study of human tissues was performed in accordance with the\n                      \n                      and was authorized by the Ethics Committee of Union Hospital of Huazhong University of Science and Technology [2025(0424-01)]. Written informed consent was obtained from all patients in this sturdy. The animal experiments were performed under the administration of Institution of Animal Care and Use Committee, Huazhong University of Science and Technology ([2024] 4416).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}],"article-number":"306"}}